Your browser doesn't support javascript.
loading
Attack phenotypes and disease course in pediatric MOGAD.
Santoro, Jonathan D; Beukelman, Timothy; Hemingway, Cheryl; Hokkanen, Suvi R K; Tennigkeit, Frank; Chitnis, Tanuja.
Affiliation
  • Santoro JD; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Beukelman T; Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, California, USA.
  • Hemingway C; Epi Excellence LLC, Garnet Valley, Pennsylvania, USA.
  • Hokkanen SRK; Great Ormond Street Hospital for Children, London, UK.
  • Tennigkeit F; UCB Pharma, Brussels, Belgium.
  • Chitnis T; UCB Biosciences, Monheim, Germany.
Ann Clin Transl Neurol ; 10(5): 672-685, 2023 05.
Article in En | MEDLINE | ID: mdl-37000895
ABSTRACT
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an autoimmune demyelinating condition that affects children differently than adults. We performed a literature review to assess the presentation and clinical course of pediatric MOGAD. The most common initial phenotype is acute disseminated encephalomyelitis, especially among children younger than five years, followed by optic neuritis (ON) and/or transverse myelitis. Approximately one-quarter of children with MOGAD have at least one relapse that typically occurs within three years of disease onset and often includes ON, even if ON was not present at onset. Clinical risk factors for a relapsing course have not been elucidated.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Optic Neuritis Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Clin Transl Neurol Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Optic Neuritis Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Clin Transl Neurol Year: 2023 Document type: Article Affiliation country: United States